Data collection from patients with interstitial lung disease
Prospective Observational Study of Patients With Interstitial Lung Disease (RESPIRARE)
This study is collecting information from adults with interstitial lung disease to better understand their treatment experiences and outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS Academic / other |
| Locations | 1 site (Rome, RM) |
| Trial ID | NCT06645977 on ClinicalTrials.gov |
What this trial studies
This observational study aims to collect prospective data from adult patients diagnosed with interstitial lung disease (ILD) at a specialized clinic. The focus is on gathering real-world information regarding the management and treatment of ILD patients. By documenting patient experiences and outcomes, the study seeks to enhance understanding of current practices in ILD care.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 years and older who have been diagnosed with interstitial lung disease according to international guidelines.
Not a fit: Patients who are unable to provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights that improve the management and treatment strategies for patients with interstitial lung disease.
How similar studies have performed: While this study focuses on observational data collection, similar studies have successfully contributed to the understanding of ILD management, indicating a potential for valuable outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \>= 18 years * Diagnosis of ILD, according to international guidelines. Exclusion Criteria: * Inability to give informed consent.
Where this trial is running
Rome, RM
- Fondazione Policlinico Universitario Agostino Gemelli — Rome, Rm, Italy (Recruiting)
Study contacts
- Study coordinator: Luca Richeldi
- Email: luca.richeldi@policlinicogemelli.it
- Phone: 0630157857
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.